PGR and colorectal cancer: Specifically, triptonide exhibited a binding energy of -9.62 kcal/mol with PGR, a core target of hypertensive retinopathy, while methyl ursolate showed a binding energy of -9.71 kcal/mol with NFE2L2, a core target of colorectal cancer.